The Precision Peptide Company Inc. (BPC)
CSE
Closed
Aug 24, 2026
Day's Range
0.430052 wk Range
0.1750Profile - BPC - The Precision Peptide Company Inc.
Profile
Mic Code
XCNQ
Sector
Consumer Defensive
Industry
Packaged Foods
Employees
0
The Precision Peptide Company Inc. is a biotechnology firm specializing in the development and production of high-purity peptides for therapeutic and research applications. The company synthesizes custom peptides tailored for medical treatments, pharmaceutical research, and clinical studies, with a focus on areas including endocrinology, immunology, and oncology. Its core offerings encompass custom peptide synthesis services, catalog peptides for standard research needs, and advanced peptide modifications such as cyclization and labeling to enhance stability and functionality. The Precision Peptide Company Inc. serves academic institutions, biotech firms, and pharmaceutical companies, providing scalable solutions ranging from small-scale research quantities to large-scale manufacturing for preclinical and clinical trials. By utilizing solid-phase peptide synthesis technology and maintaining rigorous quality controls, the company supports innovation in peptide-based therapeutics and diagnostics. Headquartered in Vancouver, British Columbia, The Precision Peptide Company Inc. operates as a key player in the peptide therapeutics market, contributing to advancements in targeted drug delivery and personalized medicine.
Profile Details
Type
Common Stock
Ceo
Mr. Pratapvir Sandhu
Address
543 Granville Street
City
Vancouver
State
BC
Zip
V6C 1X8
Country
Canada
Phone
604 765 8069
Key Executives - BPC - The Precision Peptide Company Inc.
Key executives
Cross Listings - BPC - The Precision Peptide Company Inc.
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
